Adiponectin, hepatocellular dysfunction and insulin sensitivity
- 6 January 2004
- journal article
- website
- Published by Wiley in Clinical Endocrinology
- Vol. 60 (2) , 256-263
- https://doi.org/10.1046/j.1365-2265.2004.01977.x
Abstract
Summary: objective Insulin resistance plays a major aetiological role in the development of fatty liver disease. Because adiponectin is a hepatic insulin sensitizer and also an inhibitor of tumour necrosis factor, a cytokine known to induce insulin resistance and liver damage, we wished to study whether low circulating adiponectin would be associated with higher serum concentrations of liver enzymes in healthy subjects.design Cross‐sectional, population‐based study dealing with diabetes prevalence in northern Spain.patients Two hundred and fifty‐seven apparently healthy Caucasian subjects consecutively enrolled in the study.measurements Adiponectin serum levels were measured by enzyme‐linked immunosorbent assay (ELISA), liver function tests (LFTs) by colourimetry and insulin resistance by the homeostasis model of assessment (HOMA value).results Adiponectin levels were negatively correlated with alanine aminotransferase (ALT) and γ‐glutamyltranspeptidase (GGT), before and after adjustment for sex, age, body mass index (BMI) and insulin resistance (ALT; r = −0·32, P < 0·001; adjusted: r = −0·13, P = 0·033; GGT; r = −0·31, P < 0·001; adjusted: r = −0·16, P = 0·011). Additionally, adiponectin correlated with alkaline phosphate (ALKP) only after adjusting for the same confounding variables (r =−0·10, P = 0·098; adjusted: r = −0·14, P = 0·031). A general linear model, adjusting for age, sex and BMI, was constructed to predict the decrease in circulating adiponectin for each LFT value (i.e. ALT, GGT and ALKP) above the median. Beyond one LFT value above the median, serum adiponectin decreased by –0·97 mg/l (95% CI −1·46 to −0·48). In multiple regression analysis, sex, BMI and adiponectin, but not insulin resistance, predicted serum concentrations of both ALT and GGT, explaining 19% and 14% of their variance, respectively. Age, BMI and adiponectin, but not sex or insulin resistance, explained 20% of ALKP variance.conclusions Adiponectin levels are associated in healthy humans with plasma concentrations of various liver function tests. The contributions of adiponectin to maintaining liver integrity through the regulation of both insulin sensitivity and/or the inflammatory response merit further studies.Keywords
This publication has 49 references indexed in Scilit:
- Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver diseaseHepatology, 2003
- Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic PatientsDiabetes Care, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Change in Expression of GBP28/Adiponectin in Carbon Tetrachloride-Administrated Mouse LiverBiochemical and Biophysical Research Communications, 2001
- Loss of Insulin Signaling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic DysfunctionPublished by Elsevier ,2000
- Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.Diabetes Care, 2000
- Prospective Study of Serum γ-Glutamyltransferase and Risk of NIDDMDiabetes Care, 1998
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998
- AdipoQ Is a Novel Adipose-specific Gene Dysregulated in ObesityJournal of Biological Chemistry, 1996
- A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the ratDiabetes, 1994